GAB1作为前颅底脑膜瘤复发标志物
这项双中心回顾性队列纳入2005至2015年手术的前颅底脑膜瘤患者148例,中位随访72±46个月,评估GAB1免疫组化评分与复发的关联。GAB1阳性(评分>250)占35%,与更高复发率、多次手术需求及弥漫性颅底浸润相关,多因素分析显示GAB1阳性是复发的独立预后因素。
要点
- 前颅底脑膜瘤中GAB1免疫组化阳性(评分>250)占35%,主要位于嗅沟、脑膜皮型WHO 1级。
- GAB1阳性者复发率36% vs 阴性者14%(P=.002),多次手术需求17% vs 4.2%(P=.014)。
- 多因素分析中GAB1阳性为复发独立预后因素(HR=3.2,95%CI 1.5-6.9,P=.004)。
核心结论
- GAB1标志物是前颅底脑膜瘤复发的独立预后因素,可能有助于预后评估和识别Hedgehog通路激活的脑膜瘤。
研究设计与样本
- 回顾性双中心队列,纳入2005至2015年手术的前颅底脑膜瘤患者,在2个中心进行GAB1免疫组化并评估GAB1评分,复习临床和病理资料以确定GAB1评分及经典复发因素的预后价值。
主要发现
- 共纳入148例患者,中位随访72±46个月;78%患者实现大体全切除,84%患者为WHO 1级脑膜瘤。
- GAB1免疫组化阳性(即GAB1染色评分>250)53例(35%),主要位于嗅沟、脑膜皮型WHO 1级亚型。
- GAB1阳性者复发率36% vs 阴性者14%(P=.002),多次手术需求17% vs 4.2%(P=.014),向弥漫性颅底浸润演变15% vs 3%(P=.0017)。
- 多因素Cox回归分析显示,不完全手术切除(HR=8.3,95%CI 3.7-18.2,P<.001)、男性(HR=5.4,95%CI 2.2-13.5,P<.001)、GAB1阳性(HR=3.2,95%CI 1.5-6.9,P=.004)和Ki67指数>4(HR=2.2,95%CI 1.2-4.6,P=.035)是复发的独立预后因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: About one-third of anterior skull base meningiomas show Hedgehog pathway activation. We have recently identified GAB1 as a surrogate marker for Hedgehog pathway-activated meningiomas. OBJECTIVE: To determine the reproducibility and prognostic value of GAB1 marker in anterior skull base meningiomas. METHODS: A retrospective bicentric cohort of anterior skull base meningiomas, operated from 2005 to 2015, was constituted. GAB1 immunohistochemistry was performed in 2 centers, and the GAB1 score was assessed. Clinical and pathological data were reviewed to determine the prognostic value of the GAB1 score, along with classical factors of recurrence. RESULTS: One hundred forty-eight patients were included (median follow-up of 72 ± 46 months). 78% of patients had gross total resection. Eighty-four percentage of patients harbored grade 1 meningiomas. GAB1 immunohistochemistry was positive (ie, GAB1 staining score was >250) in 53 cases (35%). GAB1-positive cases were mainly at olfactory groove, of meningothelial grade 1 subtype, and showed greater recurrence (36% vs 14%, P = .002), greater requirement for multiple surgeries (17% vs 4.2%, P = .014), and more likely evolution toward diffuse skull base infiltration (15% vs 3%, P = .0017). By multivariable Cox regression analysis, incomplete surgical resection (hazard ratios [HR] = 8.3, 95% IC [3.7-18.2], P < .001), male sex (HR = 5.4, 95% IC [2.2-13.5], P < .001), GAB1 positivity (HR = 3.2, 95% CI [1.5-6.9], P = .004), and Ki67 index >4 (HR = 2.2, 95% IC [1.2-4.6], P = .035) were independent prognostic factors for recurrence. CONCLUSION: GAB1 marker is an independent prognostic factor for anterior skull base meningioma and could be useful for both prognostic evaluation and identification of Hedgehog-activated meningiomas.
引用
- Boetto J, Bielle F, Tran S, et al. GAB1 as a Marker of Recurrence in Anterior Skull Base Meningioma. Neurosurgery. 2022. PMID: 36637273. doi:10.1227/neu.0000000000002209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。